Bayer HealthCare and Onyx Pharmaceuticals (NASDAQ: ONXX) today announced the submission of a supplemental New Drug Application (sNDA) to the U.S. Food and Drug Administration (FDA) and an application for marketing authorization to the European Medicines Agency (EMA) for the oral…
Source: Bayer, Onyx submit sNDA to FDA, marketing authorization application to EMA for Nexavar tablets
Monday, July 1, 2013
Bayer, Onyx submit sNDA to FDA, marketing authorization application to EMA for Nexavar tablets
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment